Free Trial

Cyclo Therapeutics (CYTHW) Competitors

$0.13 0.00 (0.00%)
(As of 12/17/2024 ET)

CYTHW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying Cyclo Therapeutics stock or one of its competitors? The main competitors of Cyclo Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

Cyclo Therapeutics vs.

180 Life Sciences (NASDAQ:ATNFW) and Cyclo Therapeutics (NASDAQ:CYTHW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, community ranking, valuation and earnings.

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Cyclo Therapeutics'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Cyclo Therapeutics Neutral

180 Life Sciences and Cyclo Therapeutics both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Cyclo TherapeuticsN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Cyclo Therapeutics$870.73KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Cyclo Therapeutics N/A N/A N/A

Summary

Cyclo Therapeutics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYTHW vs. The Competition

MetricCyclo TherapeuticsDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.13B$5.13B$9.28B
Dividend YieldN/A3.13%4.83%4.06%
P/E RatioN/A113.22134.1017.54
Price / SalesN/A2,159.091,159.20135.61
Price / CashN/A9.9240.5637.95
Price / BookN/A3.134.894.95
Net IncomeN/A$149.12M$118.62M$225.30M
7 Day PerformanceN/A-1.44%14.41%-0.50%
1 Month Performance-8.57%-1.74%14.72%8.08%
1 Year Performance-39.05%105.83%34.43%23.54%

Cyclo Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYTHW
Cyclo Therapeutics
N/A$0.13
flat
N/AN/A$0.00$870,725.000.009
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+41.0%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/A$0.04
-25.7%
N/AN/A$0.00$522,000.000.00N/AGap Down
AEHAW
Aesther Healthcare Acquisition
N/A$0.16
+6.2%
N/A+4.1%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$40,633.000.0040Positive News
ALVOW
Alvotech
N/A$2.78
+1.1%
N/A+12.9%$0.00$391.87M0.004Gap Up
ALVO
Alvotech
2.7632 of 5 stars
$12.05
+2.1%
$18.00
+49.4%
+13.9%$0.00$93.38M0.001,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/AN/A$0.00N/A0.004
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/AN/A$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.09
-0.1%
N/A+263.0%$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.47
flat
N/AN/A$0.00$193.06M0.00N/A

Related Companies and Tools


This page (NASDAQ:CYTHW) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners